Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

19.10 

0.00 0.0%

as of Dec 01 '22

52 Week Range:

12.40 78.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) -1.84
-2.51
-0.43
0.29
1.54
0.45
1.01
growth rate 0.0% 0.0% 100.0% 431.0% -70.8% 124.4%
Earnings BIT 562.00
377.00
387.00
193.00
332.00
202.00
88.00
186.00
growth rate -32.9% 2.7% -50.1% 72.0% -39.2% -56.4% 111.4%
Avg.PE 82.55
31.71
53.50
67.50
67.50
67.50
67.50
growth rate -61.6% 68.7% 26.2% 0.0% 0.0% 0.0%
ROA 109.84
108.78
93.18
68.71
27.08
3.26
4.37
18.39
8.38
-9.30
12.19
growth rate -1.0% -14.3% -26.3% -60.6% -88.0% 34.1% 320.8% -54.4% -100.0% 100.0%
ROE 241.73
304.26
97.45
-101.72
143.86
growth rate 25.9% -15.0% -100.0% 100.0%
ROIC 241.73
304.26
32.39
-30.71
52.63
growth rate 25.9% -27.4% -100.0% 100.0%
Cur. Ratio 1.08
0.88
0.51
1.22
1.20
0.96
1.43
1.62
1.83
1.98
1.80
growth rate -18.5% -42.1% 139.2% -1.6% -20.0% 49.0% 13.3% 13.0% 8.2% -9.1%
Quick Ratio 0.87
0.75
0.39
1.09
1.10
0.88
1.32
1.47
1.70
1.73
1.62
growth rate -13.8% -48.0% 179.5% 0.9% -20.0% 50.0% 11.4% 15.7% 1.8% -6.4%
Leverage 2.20
3.84
23.44
7.90
18.67
9.02
growth rate 74.6% 35.2% -66.3% 136.3% -51.7%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 171.00
194.00
245.00
295.00
318.00
192.00
186.00
215.00
growth rate 13.5% 26.3% 20.4% 7.8% -39.6% -3.1% 15.6%
Acct.Payable 29.00
27.00
33.00
40.00
47.00
39.00
20.00
137.00
growth rate -6.9% 22.2% 21.2% 17.5% -17.0% -48.7% 585.0%
Cur.Assets 565.00
721.00
990.00
1,225.00
1,329.00
1,360.00
1,187.00
1,444.00
growth rate 27.6% 37.3% 23.7% 8.5% 2.3% -12.7% 21.7%
Total Assets 747.00
937.00
1,209.00
1,444.00
1,547.00
1,652.00
1,531.00
1,832.00
growth rate 25.4% 29.0% 19.4% 7.1% 6.8% -7.3% 19.7%
Cash 331.00
467.00
692.00
863.00
924.00
1,060.00
858.00
1,102.00
growth rate 41.1% 48.2% 24.7% 7.1% 14.7% -19.1% 28.4%
Inventory 41.00
48.00
41.00
52.00
78.00
73.00
93.00
95.00
growth rate 17.1% -14.6% 26.8% 50.0% -6.4% 27.4% 2.2%
Cur.Liabilities 462.00
603.00
1,030.00
854.00
818.00
742.00
599.00
804.00
growth rate 30.5% 70.8% -17.1% -4.2% -9.3% -19.3% 34.2%
Liabilities 1,222.00
1,216.00
1,504.00
1,647.00
1,481.00
1,443.00
1,449.00
1,629.00
growth rate -0.5% 23.7% 9.5% -10.1% -2.6% 0.4% 12.4%
LT Debt 719.00
571.00
434.00
477.00
237.00
233.00
230.00
239.00
growth rate -20.6% -24.0% 9.9% -50.3% -1.7% -1.3% 3.9%
Equity -475.00
-279.00
-295.00
-203.00
66.00
209.00
82.00
203.00
growth rate 0.0% 0.0% 0.0% 100.0% 216.7% -60.8% 147.6%
Common Shares 147.00
147.00
144.00
145.00
147.00
149.00
150.00
73.00
73.00
73.00
70.00
growth rate 0.0% -2.0% 0.7% 1.4% 1.4% 0.7% -51.3% 0.0% 0.0% -4.1%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 27.00
27.00
20.00
30.00
11.00
7.00
4.00
4.00
growth rate 0.0% -25.9% 50.0% -63.3% -36.4% -42.9% 0.0%
Cash Dividends 500.00
23.00
69.00
growth rate -95.4% 200.0%
Cash From OA 440.00
320.00
407.00
295.00
303.00
151.00
-193.00
353.00
growth rate -27.3% 27.2% -27.5% 2.7% -50.2% -100.0% 100.0%
FCF per Share 1.79
1.83
1.74
1.37
1.14
-0.47
0.46
growth rate 2.2% -4.9% -21.3% -16.8% -100.0% 100.0%
Sale Purchase of Stock 2.00
2.00
2.00
2.00
growth rate 0.0% 0.0% 0.0%
FCF 690.00
863.00
788.00
414.00
289.00
372.00
252.00
262.00
144.00
-197.00
319.00
growth rate 25.1% -8.7% -47.5% -30.2% 28.7% -32.3% 4.0% -45.0% -100.0% 100.0%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 1,115.00
1,014.00
1,058.00
1,093.00
1,005.00
785.00
647.00
791.00
growth rate -9.1% 4.3% 3.3% -8.1% -21.9% -17.6% 22.3%
Op.Income 562.00
377.00
387.00
193.00
332.00
202.00
88.00
186.00
growth rate -32.9% 2.7% -50.1% 72.0% -39.2% -56.4% 111.4%
IBT 561.00
285.00
98.00
137.00
278.00
180.00
-173.00
190.00
growth rate -49.2% -65.6% 39.8% 102.9% -35.3% -100.0% 100.0%
Net Income 403.00
228.00
35.00
58.00
275.00
134.00
-148.00
205.00
growth rate -43.4% -84.7% 65.7% 374.1% -51.3% -100.0% 100.0%
EPS 4.17
4.12
3.40
2.80
1.55
0.25
0.40
1.85
0.90
-1.00
1.35
growth rate -1.2% -17.5% -17.7% -44.6% -83.9% 60.0% 362.5% -51.4% -100.0% 100.0%
Gross Profit 1,020.00
917.00
962.00
989.00
877.00
645.00
555.00
664.00
growth rate -10.1% 4.9% 2.8% -11.3% -26.5% -14.0% 19.6%
R&D 115.00
132.00
119.00
89.00
67.00
53.00
40.00
52.00
growth rate 14.8% -9.9% -25.2% -24.7% -20.9% -24.5% 30.0%

Quarterly Statements

Item Name Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Earnings BIT 57.00
5.00
54.00
60.00
56.00
growth rate -91.2% 980.0% 11.1% -6.7%
Balance Sheet Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Acct.Receivable 175.00
215.00
208.00
212.00
215.00
growth rate 22.9% -3.3% 1.9% 1.4%
Acct.Payable 33.00
137.00
64.00
107.00
633.00
growth rate 315.2% -53.3% 67.2% 491.6%
Cur.Assets 1,314.00
1,444.00
1,263.00
1,341.00
1,264.00
growth rate 9.9% -12.5% 6.2% -5.7%
Total Assets 1,700.00
1,832.00
1,724.00
1,720.00
1,671.00
growth rate 7.8% -5.9% -0.2% -2.9%
Cash 1,005.00
1,102.00
874.00
857.00
821.00
growth rate 9.7% -20.7% -2.0% -4.2%
Inventory 97.00
95.00
91.00
100.00
106.00
growth rate -2.1% -4.2% 9.9% 6.0%
Cur.Liabilities 712.00
804.00
728.00
787.00
744.00
growth rate 12.9% -9.5% 8.1% -5.5%
Liabilities 1,539.00
1,629.00
1,492.00
1,490.00
1,444.00
growth rate 5.9% -8.4% -0.1% -3.1%
LT Debt 239.00
239.00
238.00
237.00
237.00
growth rate 0.0% -0.4% -0.4% 0.0%
Equity 161.00
203.00
232.00
230.00
227.00
growth rate 26.1% 14.3% -0.9% -1.3%
Common Shares 72.00
70.00
71.00
70.00
69.00
growth rate -2.8% 1.4% -1.4% -1.4%
Cash Flow Statement Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Capital Expenditures 1.00
2.00
2.00
2.00
2.00
growth rate 100.0% 0.0% 0.0% 0.0%
Cash From OA 26.00
167.00
-75.00
27.00
62.00
growth rate 542.3% -100.0% 100.0% 129.6%
Sale Purchase of Stock
growth rate
FCF 25.00
165.00
-77.00
25.00
60.00
growth rate 560.0% -100.0% 100.0% 140.0%
Income Statement Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Sales 187.00
223.00
207.00
221.00
232.00
growth rate 19.3% -7.2% 6.8% 5.0%
Op.Income 57.00
5.00
54.00
60.00
56.00
growth rate -91.2% 980.0% 11.1% -6.7%
IBT 31.00
40.00
48.00
58.00
54.00
growth rate 29.0% 20.0% 20.8% -6.9%
Net Income 27.00
36.00
41.00
48.00
41.00
growth rate 33.3% 13.9% 17.1% -14.6%
Gross Profit 161.00
176.00
170.00
183.00
192.00
growth rate 9.3% -3.4% 7.7% 4.9%
R&D 11.00
19.00
8.00
14.00
20.00
growth rate 72.7% -57.9% 75.0% 42.9%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (31.73)

YOY Growth Grade:

F (4.22)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 36.50 37.09
EPS / Growth 0.52

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 50.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 40.0% 50.0% 84.5%
Future PE 0.01 24.34 68.51
Future EPS 14.90 29.70 235.51
Value Price
MOS %
0.04
-99.8%
178.65
835.3%
3,988.25
20,780.9%
MOS Price 0.02 89.33 1,994.12
IRT 7.25 6.35 4.65

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.